US Patent 7304061 Heterocyclic inhibitors of ERK2 and uses thereof

Patent 7304061 was granted and assigned to Vertex Pharmaceuticals on December, 2007 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73040610

Patent Inventor Names

Alexander Aronov0

Judith Straub0

Michael Robin Hale0

Qing Tang0

Francois Maltais0

Date of Patent

December 4, 2007

Patent Application Number

104242800

Date Filed

April 25, 2003

Patent Citations Received

‌

US Patent 11980633 Method for treating cancer using a combination of DNA-damaging agents and DNA-PK inhibitors

Patent Primary Examiner

‌

Deepak Rao

Patent abstract

Described herein are compounds that are useful as protein kinase inhibitors having the formula:

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7304061 Heterocyclic inhibitors of ERK2 and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API